Barclays »

Axsome Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 296k 79.59
2023-09-30 $1.2M 17k 69.89
2023-06-30 $5.0k 73 68.49
2022-09-30 $1.2M 27k 44.63
2021-09-30 $2.0M 60k 32.96
2021-06-30 $7.0M 104k 67.71
2021-03-31 $2.0M 35k 56.61
2020-12-31 $931k 11k 81.44
2020-09-30 $815k 11k 71.29
2020-06-30 $1.5M 18k 82.28
2020-03-31 $14M 241k 58.80
2019-12-31 $17M 160k 103.36
2019-09-30 $604k 30k 20.20
2019-06-30 $2.8M 108k 25.86
2019-03-31 $2.6M 183k 14.23
2018-12-31 $30k 11k 2.86
2018-06-30 $117k 37k 3.20
2018-03-31 $87k 36k 2.44
2017-09-30 $97k 18k 5.54
2017-06-30 $89k 16k 5.50
2017-03-31 $30k 7.9k 3.82
2016-12-31 $999 139 7.19
2016-09-30 $1.0k 139 7.25